Myriad Genetics sell JPMorgan Chase & Co.
Start price
07.11.23
/
50%
€16.70
Target price
07.11.24
€13.08
Performance (%)
2.40%
End price
08.11.24
€17.10
Summary
This prediction ended on 08.11.24 with a price of €17.10. The SELL prediction by JPMorgan_Chase___Co_ shows the price for Myriad Genetics slightly increased by 2.40% during the runtime of the prediction. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Myriad Genetics | -3.292% | -3.292% | 5.690% |
| iShares Core DAX® | -1,78 % | 2,48 % | 1,47 % |
| iShares Nasdaq 100 | 1,52 % | 3,29 % | 33,72 % |
| iShares Nikkei 225® | 1,08 % | 7,04 % | 59,26 % |
| iShares S&P 500 | 0,93 % | 3,25 % | 24,73 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at JPMorgan Chase & Co. from $17.00 to $14.00. They now have an "underweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten